PI3K inhibitor CAL-101, Purity ≥98%

Cat. No.: X24-05-ZQ081

PI3K inhibitor CAL-101, Purity ≥98%

Synonym: 870281-82-6; CAL101; GS-1101; Idelalisib; PI3K inhibitor

  • CAS Number: 870281-82-6
  • Compound CID: 11625818
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
CAL-101, soluble in warmed DMSO and ethanol and insoluble in water, is a potent compound that inhibits PI3 kinase activity. It targets p110β, p110γ, C2β, DNA-PK, hVPS34, mTOR, p110α, p110δ, PIP5Kα, and PIP5Kβ.
Molecular Weight
415.4
Molecular Formula
C22H18FN7O
Targets
p110β: 565 nM; p110γ: 89 nM; C2β: >1 μM; DNA-PK: 6.729 μM; hVPS34: 978 nM; mTOR: >1 μM; p110α: 820 nM; p110δ: 2.5 nM; PIP5Kα: >1 μM; PIP5Kβ: >1 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 76 mg/mL (182.94 mM); Water: Insoluble; Ethanol: 21 mg/mL (50.55 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CAL-101, known as idelalisib, is utilized to study its role as a PI3K δ inhibitor, especially in B-cell malignancies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.